There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease #osteoarthritis NEW Data drop at #ADA2023: Retatrutide, a triple agonist (GLP1, GIP, glucagon) lost an incredible 24.2% of their body weight, which amounts to 58 lbs
(PubMed) Ahsan H, Ahad A, Iqbal J, Siddiqui WA
A review of the FDA adverse event database revealed an increased incidence of thyroid cancer with exenatide whn compared with a control drug ( J Clin Endocrinol Metabolism
Horizontal axis: Evidence strength. Vertical axis: Claim scope. Place topical skin aging and wound-care context closer to stronger evidence
Instead, the change tends to feel like the heavy, dragging feeling slowly lifting
General medical consultation: If you have any chronic health conditions or take prescription medications, discussing supplement use with your healthcare provider is always advisable before beginning any new product